Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH

Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: A study among a U.S. cohort of commercial insurance enrollees

(2015) Hussain R. Yusuf et al.   THROMBOSIS RESEARCH

Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism

(2014) C. Kearon et al.   BLOOD

Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology

(2014) Geoffrey C. Nguyen et al.   GASTROENTEROLOGY

Epidemiology of cancer-associated venous thrombosis

(2013) J. F. Timp et al.   BLOOD

Venous thrombosis: understanding the paradoxes of recurrence

(2013) S. C. Cannegieter et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Antithrombotic Therapy for VTE Disease

(2012) Clive Kearon et al.   CHEST

Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization

(2012) Marie E. Holmqvist et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Infections and inflammatory diseases as risk factors for venous thrombosis

(2012) Hanneke J. C. Kluin-Nelemans et al.   THROMBOSIS AND HAEMOSTASIS

Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden

(2011) Bengt Zöller et al.   LANCET

Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor

(2010) Alfonso Iorio et al.   ARCHIVES OF INTERNAL MEDICINE

Risk assessment for recurrent venous thrombosis

(2010) Paul Alexander Kyrle et al.   LANCET

Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study

(2010) Matthew J Grainge et al.   LANCET